Get Your Personalized Supplement StackSupplement Stack Quiz

Scullcap herb

Also known as: Scutellaria baicalensis, Scutellaria lateriflora, Skullcap, Chinese skullcap, American skullcap

Overview

Skullcap is a genus of flowering plants, with Scutellaria baicalensis and Scutellaria lateriflora being the most common species used in herbal medicine. Traditionally, it has been used for its purported anxiolytic, sedative, anti-inflammatory, and neuroprotective properties. The dried leaves and stems are commonly consumed as extracts or teas. It is primarily used to treat anxiety, stress, insomnia, and sometimes pain or inflammation. Research on skullcap is moderate but lacks extensive high-quality clinical trials; much of the evidence is preclinical or observational. A significant concern is the documented risk of herb-induced liver injury (HILI), necessitating caution in its use.

Benefits

Skullcap is traditionally used for anxiety and insomnia relief. Preclinical evidence suggests potential antidepressant and neuroprotective effects, but these findings are preliminary and primarily from animal or in vitro studies. Some research indicates anti-inflammatory and antioxidant properties, but robust clinical data are lacking. While used mainly in adults with anxiety or sleep disturbances, the efficacy has not been confirmed by large, rigorous randomized controlled trials (RCTs). The effect sizes and clinical significance are not well established due to the limited availability of high-quality RCT data. Traditional use suggests effects over days to weeks, but precise clinical timelines have not been established.

How it works

Skullcap contains flavonoids such as baicalin, baicalein, and wogonin, which may modulate GABAergic activity, potentially contributing to its anxiolytic and sedative effects. The anti-inflammatory and antioxidant effects are attributed to the inhibition of pro-inflammatory cytokines and oxidative stress pathways. The absorption and bioavailability of these active flavonoids vary, with baicalin being metabolized in the liver. Further research is needed to fully elucidate the mechanisms of action and bioavailability of skullcap's active compounds.

Side effects

Skullcap has been associated with herb-induced liver injury (HILI), posing a significant risk of hepatotoxicity. Common side effects are not well-quantified, but mild gastrointestinal symptoms have been occasionally reported. Uncommon side effects include liver enzyme elevations, nausea, choluria (dark urine), and jaundice, indicative of liver injury. Rare side effects include autoimmune hepatitis and severe liver injury, potentially requiring liver transplantation. Potential drug interactions exist, especially with other hepatotoxic drugs or those metabolized by liver enzymes, necessitating caution. It is contraindicated in individuals with pre-existing liver disease or known sensitivity to skullcap components. Middle-aged women appear to have a higher prevalence of skullcap-induced liver injury.

Dosage

Reported ingested doses associated with liver injury cases range widely from 400 mg to 16 g daily. There is no established minimum effective dose due to the lack of rigorous clinical trials. Optimal dosing and the maximum safe dose are not well defined, warranting caution given the hepatotoxicity risk. Liver injury onset has been reported to range from 1 to 12 weeks after starting supplementation. Extracts and teas are common forms, but standardization of active compounds varies. Due to the potential for liver injury, it is crucial to exercise caution and consult with a healthcare professional before using skullcap.

FAQs

Is skullcap safe to use?

There is a significant risk of liver injury with skullcap supplements, including severe cases; safety monitoring is essential. Consult with a healthcare provider before use.

How quickly do effects appear?

Traditional use suggests effects within days to weeks, but clinical evidence is limited. Individual responses may vary, and more research is needed.

Can skullcap be used long-term?

Long-term safety is uncertain, especially due to the risk of hepatotoxicity. Regular monitoring of liver function is advisable if long-term use is considered.

Does skullcap interact with medications?

Potentially yes, especially with other hepatotoxic drugs or those metabolized by liver enzymes. Consult with a healthcare provider to assess potential interactions.

Is skullcap effective for anxiety or insomnia?

Evidence is mostly preclinical or anecdotal; high-quality clinical trials are lacking. Other evidence-based treatments should be considered first.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC10941739/ – This systematic review and case report analyzed 936 cases of herb-induced liver injury (HILI), including skullcap. The findings indicate that skullcap-induced liver injury is typically hepatocellular, with a mortality rate of 14.2%. Symptoms usually appear within 1-12 weeks after starting use, and liver function generally normalizes within 3 months after cessation.
https://pubmed.ncbi.nlm.nih.gov/34307603/ – This systematic review and meta-analysis examined 936 cases of herb-induced liver injury (HILI) involving 79 different herbs. Skullcap was identified as one of the herbs with notable hepatotoxicity, with a mortality rate of 14.2% in skullcap-induced HILI cases. The study also found that the hepatocellular injury pattern was predominant, and there was a higher prevalence of HILI in women.
https://f6publishing.blob.core.windows.net/60b36e01-49d1-4716-9398-22bc70511eb4/WJH-16-120.pdf – This study provides data on herb-induced liver injury, highlighting skullcap as a potential cause. It emphasizes the importance of recognizing and managing HILI, especially with the increasing use of herbal supplements. The research underscores the need for careful monitoring and awareness of the risks associated with skullcap consumption.
https://www.wjgnet.com/2307-8960/full/v9/i20/5490.htm – This article discusses the clinical features and outcomes of drug-induced liver injury, including cases caused by herbal medications like skullcap. It highlights the importance of early diagnosis and management to improve patient outcomes. The study contributes to the understanding of the patterns and risk factors associated with herb-induced liver injury.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1313871/full – This preclinical study explores the pharmacological effects of Scutellaria baicalensis, suggesting potential antidepressant-like effects and modulation of neurobiological pathways. The research provides preliminary evidence of therapeutic benefits, but it is important to note that these findings are from animal and in vitro studies and require confirmation through human clinical trials.